Provided is a pharmaceutical composition for treating a microbial imbalance, the composition comprising a pharmaceutically effective amount of at least one strain of probiotic bacteria, a pharmaceutically effective amount of cannabidiol and a pharmaceutically acceptable excipient. Further provided are feminine hygiene products comprising the composition and methods of use of the composition.

Provided is a pharmaceutical composition for treating a microbial imbalance, the composition comprising a pharmaceutically effective amount of at least one strain of probiotic bacteria, a pharmaceutically effective amount of cannabidiol and a pharmaceutically acceptable excipient. Further provided are feminine hygiene products comprising the composition and methods of use of the composition.

A biodegradable disposable diaper includes an inner layer comprising a soft, non-woven fabric, the inner layer for resting against a wearer's skin and allowing the passage of bodily waste fluids, a middle layer comprising superabsorbent polymer for absorbing and retaining the bodily waste fluids, an outer layer comprising a liquid impermeable membrane, the outer layer for restricting the passage of bodily waste fluids, and a frangible capsule, dispenser or packet containing a substance comprising mycelium, fungal spores and/or enzymes configured for using bodily waste to grow and degrading the biodegradable disposable diaper in a disposal environment, the frangible capsule, dispenser or packet further for allowing the deposition of the substance into the diaper at the time of disposal. A substance configured for using bodily waste to grow and degrading a biodegradable disposable diaper in a disposal environment, the substance configured for deposition onto the diaper.

A biodegradable disposable diaper includes an inner layer comprising a soft, non-woven fabric, the inner layer for resting against a wearer's skin and allowing the passage of bodily waste fluids, a middle layer comprising superabsorbent polymer for absorbing and retaining the bodily waste fluids, an outer layer comprising a liquid impermeable membrane, the outer layer for restricting the passage of bodily waste fluids, and a frangible capsule, dispenser or packet containing a substance comprising mycelium, fungal spores and/or enzymes configured for using bodily waste to grow and degrading the biodegradable disposable diaper in a disposal environment, the frangible capsule, dispenser or packet further for allowing the deposition of the substance into the diaper at the time of disposal. A substance configured for using bodily waste to grow and degrading a biodegradable disposable diaper in a disposal environment, the substance configured for deposition onto the diaper.

A composition or matrix comprising a bacteriophage and nanofibrillar cellulose or a derivative thereof in a wet or dry state is disclosed.

A composition or matrix comprising a bacteriophage and nanofibrillar cellulose or a derivative thereof in a wet or dry state is disclosed.

Provided is a growth inhibitor for Clostridioides difficile. A growth inhibitor for Clostridioides difficile, comprising killed Enterococcus faecalis. Also provided are a parenteral pharmaceutical preparation, a bactericide, a disinfectant, an antibacterial agent, a sanitizer or a detergent for inhibiting the growth of Clostridioides difficile.

Disclosed herein is a particle delivery system comprising electrospun nanofiber comprised of coaxial fiber with a microfluidic core. Iron-doped apatite nanoparticles (IDANPs) have demonstrated a unique influence over phage killing of bacteria, whereby, IDANP-exposed bacterial cultures experience 2× the bacterial death as controls. IDANPs consist of hydroxyapatite (HA) doped with iron. HA is a mineral known to be biocompatible and analogous to the inorganic constituent of mammalian bone and teeth and has been approved by the Food and Drug Administration (FDA) for many applications in medicine and dentistry. Previous work has shown that for IDANPs to enhance antibacterial activity of phage to the greatest extent, bacterial cultures should be exposed to IDANPs for 1 hr prior to phage introduction. Biocompatible polymer materials which encase IDANPs and/or phage can be used to disseminate IDANPs and/or phage in a controlled manner into a physiological system for treatment of bacterial infection. When components of said materials contain micro- or nano-scale components, high surface-to-volume ratio for treatment delivery is garnered.

The present invention can provide a sanitary absorbent article which includes a Lactobacillus formulation inside an absorbent pad to absorb bodily secretions and effectively remove odor thereof without leakage of the Lactobacillus to the outside of the absorbent pad.

The present invention can provide a sanitary absorbent article which includes a Lactobacillus formulation inside an absorbent pad to absorb bodily secretions and effectively remove odor thereof without leakage of the Lactobacillus to the outside of the absorbent pad.